- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Neurological Biomarkers market will register a 10.0% CAGR in terms of revenue, the global market size will reach $ 8158.2 million by 2025, from $ 5580.6 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Neurological Biomarkers business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurological Biomarkers market by type, application, key manufacturers and key regions and countries.
This study considers the Neurological Biomarkers value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Proteomics
Genomics
Imaging
Bioinformatics
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Diagnostics
Drug Discovery
Personalized Medicine
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher Scientific
Cisbio Bioassays
Merck
Abbott
Roche
Quest Diagnostics
QIAGEN
Illumina
Myriad RBM
Bio-Rad Laboratories
Genewiz
Athena Diagnostics
Aepodia
Wuxi APP
Proteome Sciences
BGI
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Neurological Biomarkers consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Neurological Biomarkers market by identifying its various subsegments.
Focuses on the key global Neurological Biomarkers manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neurological Biomarkers with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Neurological Biomarkers submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neurological Biomarkers Consumption 2015-2025
2.1.2 Neurological Biomarkers Consumption CAGR by Region
2.2 Neurological Biomarkers Segment by Type
2.2.1 Proteomics
2.2.2 Genomics
2.2.3 Imaging
2.2.4 Bioinformatics
2.2.5 Others
2.3 Neurological Biomarkers Consumption by Type
2.3.1 Global Neurological Biomarkers Consumption Market Share by Type (2015-2020)
2.3.2 Global Neurological Biomarkers Revenue and Market Share by Type (2015-2020)
2.3.3 Global Neurological Biomarkers Sale Price by Type (2015-2020)
2.4 Neurological Biomarkers Segment by Application
2.4.1 Diagnostics
2.4.2 Drug Discovery
2.4.3 Personalized Medicine
2.4.4 Others
2.5 Neurological Biomarkers Consumption by Application
2.5.1 Global Neurological Biomarkers Consumption Market Share by Type (2015-2020)
2.5.2 Global Neurological Biomarkers Value and Market Share by Type (2015-2020)
2.5.3 Global Neurological Biomarkers Sale Price by Type (2015-2020)
3 Global Neurological Biomarkers by Company
3.1 Global Neurological Biomarkers Sales Market Share by Company
3.1.1 Global Neurological Biomarkers Sales by Company (2018-2020)
3.1.2 Global Neurological Biomarkers Sales Market Share by Company (2018-2020)
3.2 Global Neurological Biomarkers Revenue Market Share by Company
3.2.1 Global Neurological Biomarkers Revenue by Company (2018-2020)
3.2.2 Global Neurological Biomarkers Revenue Market Share by Company (2018-2020)
3.3 Global Neurological Biomarkers Sale Price by Company
3.4 Global Neurological Biomarkers Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Neurological Biomarkers Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Neurological Biomarkers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Neurological Biomarkers by Regions
4.1 Neurological Biomarkers by Regions
4.2 Americas Neurological Biomarkers Consumption Growth
4.3 APAC Neurological Biomarkers Consumption Growth
4.4 Europe Neurological Biomarkers Consumption Growth
4.5 Middle East & Africa Neurological Biomarkers Consumption Growth
5 Americas
5.1 Americas Neurological Biomarkers Consumption by Countries
5.1.1 Americas Neurological Biomarkers Consumption by Countries (2015-2020)
5.1.2 Americas Neurological Biomarkers Value by Countries (2015-2020)
5.2 Americas Neurological Biomarkers Consumption by Type
5.3 Americas Neurological Biomarkers Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Neurological Biomarkers Consumption by Regions
6.1.1 APAC Neurological Biomarkers Consumption by Regions (2015-2020)
6.1.2 APAC Neurological Biomarkers Value by Regions (2015-2020)
6.2 APAC Neurological Biomarkers Consumption by Type
6.3 APAC Neurological Biomarkers Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Neurological Biomarkers by Countries
7.1.1 Europe Neurological Biomarkers Consumption by Countries (2015-2020)
7.1.2 Europe Neurological Biomarkers Value by Countries (2015-2020)
7.2 Europe Neurological Biomarkers Consumption by Type
7.3 Europe Neurological Biomarkers Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Neurological Biomarkers by Countries
8.1.1 Middle East & Africa Neurological Biomarkers Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Neurological Biomarkers Value by Countries (2015-2020)
8.2 Middle East & Africa Neurological Biomarkers Consumption by Type
8.3 Middle East & Africa Neurological Biomarkers Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Neurological Biomarkers Distributors
10.3 Neurological Biomarkers Customer
11 Global Neurological Biomarkers Market Forecast
11.1 Global Neurological Biomarkers Consumption Forecast (2021-2025)
11.2 Global Neurological Biomarkers Forecast by Regions
11.2.1 Global Neurological Biomarkers Forecast by Regions (2021-2025)
11.2.2 Global Neurological Biomarkers Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Neurological Biomarkers Forecast by Type
11.8 Global Neurological Biomarkers Forecast by Application
12 Key Players Analysis
12.1 Thermo Fisher Scientific
12.1.1 Company Information
12.1.2 Neurological Biomarkers Product Offered
12.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Thermo Fisher Scientific Latest Developments
12.2 Cisbio Bioassays
12.2.1 Company Information
12.2.2 Neurological Biomarkers Product Offered
12.2.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Cisbio Bioassays Latest Developments
12.3 Merck
12.3.1 Company Information
12.3.2 Neurological Biomarkers Product Offered
12.3.3 Merck Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Merck Latest Developments
12.4 Abbott
12.4.1 Company Information
12.4.2 Neurological Biomarkers Product Offered
12.4.3 Abbott Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Abbott Latest Developments
12.5 Roche
12.5.1 Company Information
12.5.2 Neurological Biomarkers Product Offered
12.5.3 Roche Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Roche Latest Developments
12.6 Quest Diagnostics
12.6.1 Company Information
12.6.2 Neurological Biomarkers Product Offered
12.6.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Quest Diagnostics Latest Developments
12.7 QIAGEN
12.7.1 Company Information
12.7.2 Neurological Biomarkers Product Offered
12.7.3 QIAGEN Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 QIAGEN Latest Developments
12.8 Illumina
12.8.1 Company Information
12.8.2 Neurological Biomarkers Product Offered
12.8.3 Illumina Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Illumina Latest Developments
12.9 Myriad RBM
12.9.1 Company Information
12.9.2 Neurological Biomarkers Product Offered
12.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Myriad RBM Latest Developments
12.10 Bio-Rad Laboratories
12.10.1 Company Information
12.10.2 Neurological Biomarkers Product Offered
12.10.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Bio-Rad Laboratories Latest Developments
12.11 Genewiz
12.11.1 Company Information
12.11.2 Neurological Biomarkers Product Offered
12.11.3 Genewiz Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Genewiz Latest Developments
12.12 Athena Diagnostics
12.12.1 Company Information
12.12.2 Neurological Biomarkers Product Offered
12.12.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Athena Diagnostics Latest Developments
12.13 Aepodia
12.13.1 Company Information
12.13.2 Neurological Biomarkers Product Offered
12.13.3 Aepodia Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Aepodia Latest Developments
12.14 Wuxi APP
12.14.1 Company Information
12.14.2 Neurological Biomarkers Product Offered
12.14.3 Wuxi APP Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Wuxi APP Latest Developments
12.15 Proteome Sciences
12.15.1 Company Information
12.15.2 Neurological Biomarkers Product Offered
12.15.3 Proteome Sciences Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Proteome Sciences Latest Developments
12.16 BGI
12.16.1 Company Information
12.16.2 Neurological Biomarkers Product Offered
12.16.3 BGI Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 BGI Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Neurological Biomarkers Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Player
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
